tiprankstipranks

Bob Oliver Insider Profile

4 Followers
Bob Oliver, Director at Exelixis, holds 29.49K shares in Exelixis (Ticker: EXEL), holds ― shares in Immunomedics (Ticker: IMMU).
tipranks
Bob Oliver

Bob Oliver
Exelixis (EXEL)
Director

Ranked #76,610 out of 108,921 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-25.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Bob Oliver's holdings

Insider Roles

Exelixis
(EXEL)
Director
Roles that Bob Oliver holds in companies

Most Profitable Insider Trade

Stock:
Exelixis
(EXEL)
Rating:Informative Sell
Date:Feb 26, 2025 - Feb 26, 2026
Return:-17.90%
The most profitable trade made by Bob Oliver

Bob Oliver's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Exelixis
May 29, 2026
Director
Uninformative Buy
$1.72M
IMMU
Immunomedics
List of latest transactions for each holding click on a transaction to see Bob Oliver's performance on stock

Bob Oliver insider profile FAQ

What is the percentage of profitable transactions made by Bob Oliver?
The percentage of profitable transactions made by Bob Oliver is 0%.
    What is the average return per transaction made by Bob Oliver?
    The average return per transaction made by Bob Oliver is -25.20%.
      What stocks does Bob Oliver hold?
      Bob Oliver holds: EXEL, IMMU stocks.
        What was Bob Oliver’s latest transaction?
        Bob Oliver latest transaction was an Uninformative Buy of ―.
          What was Bob Oliver's most profitable transaction?
          Bob Oliver’s most profitable transaction was an Informative Sell of EXEL stock on February 26, 2025. The return on the trade was -17.90%.
            What is Bob Oliver's role in Exelixis?
            Bob Oliver's role in Exelixis is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.